newsfilter
← Latest News
Business Wire·

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Scholar Rock granted inducement equity awards covering 83,102 shares to ten newly hired employees.
  • The awards consist of stock options for 23,801 shares & restricted stock units for 59,301 shares.
  • The inducement stock options have an exercise price of $51.85, based on the closing price on September 14, 2026.
  • Stock options vest 25% on the first anniversary of employment start dates, with the remaining 75% vesting in 12 equal quarterly installments.
  • Restricted stock units vest in four equal annual installments.
  • All vesting is contingent upon the employees' continuing service through the applicable vesting dates.
  • The grants were made under the Company's 2022 Inducement Equity Plan pursuant to Nasdaq Listing Rule 5635(c)(4).
  • Scholar Rock intends to commercialize ISEMBYLD globally for individuals with spinal muscular atrophy aged 2 years & older.
  • The company operates as a global leader in myostatin biology to treat rare neuromuscular diseases.